Latest News Archive

Please select Category, Year, and then Month to display items

Dr Molapo Qhobela to speak at International Summit on SDGs

10 September 2021 | Story Leonie Bolleurs | Photo Sonia Small (Kaleidoscope Studios)

Dr Molapo copy — Dr Molapo Qhobela, the newly appointed Vice-Rector: Institutional Change, Strategic Partnerships and Societal Impact, will be speaking at the International Summit on the Sustainable Development Goals (SDGs) in Africa 2021.

Dr Molapo Qhobela, the newly appointed Vice-Rector: Institutional Change, Strategic Partnerships and Societal Impact at the University of the Free State (UFS), will be speaking at the three-day International Summit on the Sustainable Development Goals (SDGs) in Africa 2021. The summit will take place as follows:

Date: 13-15 September 2021

Platform: A virtual gathering (register for the upcoming virtual summit)

Together with a wide array of thought leaders, including specialists, senior researchers, CEOs/directors, and the top structures of international organisations, he will address and engage with an audience of academics, practitioners, government authorities, representatives from civil society, and donors and sponsors from across the globe on the topic Partnerships for impact in Africa (session on 15 September from 12:30 to 14:00).

According to the host of the event, the University of Cape Town, the key aim of the International Summit on the SDGs in Africa is to mobilise collaborative efforts that will accelerate African-led activities in support of achieving the African Union's Agenda 2063 and the United Nations Sustainable Development Goals (SDGs) – a shared blueprint for working towards global peace and prosperity by 2030. The summit is also designed to identify concrete opportunities for research collaboration that will accelerate the achievement of the SDGs and Agenda 2063.

The talks, panel discussions, workshops, and breakout sessions will revolve around clear steps for implementation.

For more information, visit: http://www.sdgsafricasummit.uct.ac.za/

• Background of Dr Molapo Qhobela

Dr Qhobela’s leadership and strategic direction have been sought by several large and complex organisations during his career. He is the immediate former Chief Executive Officer (CEO) of the National Research Foundation, and also the former Chair of the Global Research Council as well as the Agricultural Research Council. He is currently the Chairperson of the Tertiary Education and Research Network of South Africa. Dr Qhobela holds a PhD in Plant Pathology from the Kansas State University in the United States of America.

News Archive

DNA sequencer launched at the UFS

2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept